首页 > 最新文献

Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma最新文献

英文 中文
[Thrombosis of the portal vein]. [门静脉血栓形成]。
L Calabrese, P Solli, P Soliani, P Dell'Abate, E Foggi

The portal venous thrombosis is an infrequent disease that accounts from 0.25 to 1%. The etiopathogenesis is unknown in about one half of cases. Sometimes the thrombosis of mesenterico-portal venous axis is a complication following splenectomy, especially when the operation is performed for hematologic disease. The authors report a clinical case of chronic portal venous thrombosis widespread to superior mesenteric and splenic vein, in man 38 years old after splenectomy, in pediatric age, manifesting with gastrointestinal bleeding due to rupture of esophagogastric varices. On the basis of literature, the following were taken into consideration the incidence, the epidemiology, the aetiopathogenesis, the clinical characteristics, the diagnosis as well as the therapy of portal venous thrombosis.

门静脉血栓形成是一种罕见的疾病,约占0.25 ~ 1%。大约一半的病例病因不明。有时肠系膜-门静脉轴血栓形成是脾切除术后的并发症,特别是当手术是为血液系统疾病。作者报告了一例慢性门静脉血栓扩散至肠系膜上静脉和脾静脉的临床病例,患者年龄38岁,脾切除术后,表现为食管胃静脉曲张破裂引起的胃肠道出血。本文在查阅文献的基础上,就门静脉血栓形成的发病率、流行病学、病因、临床特点、诊断及治疗等方面进行综述。
{"title":"[Thrombosis of the portal vein].","authors":"L Calabrese,&nbsp;P Solli,&nbsp;P Soliani,&nbsp;P Dell'Abate,&nbsp;E Foggi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The portal venous thrombosis is an infrequent disease that accounts from 0.25 to 1%. The etiopathogenesis is unknown in about one half of cases. Sometimes the thrombosis of mesenterico-portal venous axis is a complication following splenectomy, especially when the operation is performed for hematologic disease. The authors report a clinical case of chronic portal venous thrombosis widespread to superior mesenteric and splenic vein, in man 38 years old after splenectomy, in pediatric age, manifesting with gastrointestinal bleeding due to rupture of esophagogastric varices. On the basis of literature, the following were taken into consideration the incidence, the epidemiology, the aetiopathogenesis, the clinical characteristics, the diagnosis as well as the therapy of portal venous thrombosis.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"69 1-2","pages":"37-45"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20892778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Color Doppler echography in the diagnosis of deep venous thrombosis of the lower limbs]. [彩色多普勒超声在下肢深静脉血栓诊断中的应用]。
A A Lombardi, A Miselli, P Bresciani, G Soana, S Cocchi

Deep venous thrombosis (DVT) is a common and severe disease which can produce a pulmonary embolism as an acute consequence and post-phlebitic syndrome as a late complication. Since DVT symptoms and clinical features are almost no sensitive and specific, its diagnosis is usually achieved by instrumental exams. Until few years ago phlebography was considered the "gold standard" diagnostic test, although its invasivity prevented it from becoming routinely used in symptomatic and non-symptomatic patients. The aim of our study was to emphasize the usefulness of echo color Doppler (ECD), a non-invasive method, as a first-choice exam to diagnose and manage the therapy of DVT symptomatic patients and to address an early diagnosis in high risk non-symptomatic patients. We studied 375 patients, aged from 13 months to 92 years. In most of the cases patients were seen because suffering from DVT symptoms, after surgery, or because suspected to have a pulmonary embolism. All the patients underwent a venous ECD of the lower limbs, whereas 16 of them had also a phlebography. ECD disclosed an acute DVT in 15% of the patients and a chronic DVT in 3% of them, whereas 17% of the cases were diagnosed as having other pathologies which can clinically mimic a DVT. ECD sensitivity and specificity is higher than that of other exams, both invasive and non invasive, as it allows a thorough assessment of both iliac and distal vessels, a better detection of non-occluding wall thrombi, and has been found to be very helpful in the evaluation of chronic DVT changes.

深静脉血栓形成(DVT)是一种常见而严重的疾病,可产生肺栓塞作为急性后果和静脉栓塞后综合征作为晚期并发症。由于深静脉血栓的症状和临床特征几乎没有敏感性和特异性,其诊断通常通过仪器检查来实现。直到几年前,静脉造影还被认为是“金标准”诊断测试,尽管它的侵入性阻碍了它在有症状和无症状患者中的常规应用。本研究的目的是强调回声彩色多普勒(ECD)作为诊断和管理DVT症状患者治疗的首选检查方法的有效性,并解决高风险无症状患者的早期诊断问题。我们研究了375例患者,年龄从13个月到92岁不等。在大多数病例中,患者因患有深静脉血栓症状、手术后或疑似肺栓塞而就诊。所有患者都进行了下肢静脉ECD,其中16例还进行了静脉造影。ECD显示15%的患者为急性DVT, 3%的患者为慢性DVT,而17%的病例被诊断为具有临床模拟DVT的其他病理。ECD的敏感性和特异性高于其他检查,无论是侵入性检查还是非侵入性检查,因为它可以全面评估髂和远端血管,更好地检测非闭塞性壁血栓,并且在评估慢性DVT变化方面非常有帮助。
{"title":"[Color Doppler echography in the diagnosis of deep venous thrombosis of the lower limbs].","authors":"A A Lombardi,&nbsp;A Miselli,&nbsp;P Bresciani,&nbsp;G Soana,&nbsp;S Cocchi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Deep venous thrombosis (DVT) is a common and severe disease which can produce a pulmonary embolism as an acute consequence and post-phlebitic syndrome as a late complication. Since DVT symptoms and clinical features are almost no sensitive and specific, its diagnosis is usually achieved by instrumental exams. Until few years ago phlebography was considered the \"gold standard\" diagnostic test, although its invasivity prevented it from becoming routinely used in symptomatic and non-symptomatic patients. The aim of our study was to emphasize the usefulness of echo color Doppler (ECD), a non-invasive method, as a first-choice exam to diagnose and manage the therapy of DVT symptomatic patients and to address an early diagnosis in high risk non-symptomatic patients. We studied 375 patients, aged from 13 months to 92 years. In most of the cases patients were seen because suffering from DVT symptoms, after surgery, or because suspected to have a pulmonary embolism. All the patients underwent a venous ECD of the lower limbs, whereas 16 of them had also a phlebography. ECD disclosed an acute DVT in 15% of the patients and a chronic DVT in 3% of them, whereas 17% of the cases were diagnosed as having other pathologies which can clinically mimic a DVT. ECD sensitivity and specificity is higher than that of other exams, both invasive and non invasive, as it allows a thorough assessment of both iliac and distal vessels, a better detection of non-occluding wall thrombi, and has been found to be very helpful in the evaluation of chronic DVT changes.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"69 3-4","pages":"105-12"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21365551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic and therapeutic approaches for masses in the posterior mediastinum. 后纵隔肿块的诊断和治疗方法。
D Divisi, C Battaglia, R Crisci, L Giusti, A Lococo, M Vaccarili, G F Coloni

Between January 1980 and December 1997 twenty-one patients with a mass in the posterior mediastinum came under our observation. All of the patients underwent chest radiography, bronchoscopy, respiratory function tests, perfusional and ventilatory radionuclide scans, a computed tomography (CT) of the chest and blood gas analysis. In cases involving neurogenic tumours magnetic resonance imaging (MRI) was used. Ten patients underwent CT guided transthoracic needle biopsy. The excision was performed by means of a thoracotomy in 12 cases (57.1%) and by video assisted thoracoscopy surgery (VATS) in the other 9 (42.9%); no deaths were recorded. Eleven neurilemmomas, two bronchogenic cysts, two paragangliomas, two neuroepitheliomas, one neurogenic sarcoma and three esophageal duplications were found. The authors believe an accurate pre-operative assessment of the lesion can be obtained using CT and MRI. The video assisted thoracoscopy (VAT) is a useful method of diagnosis and treatment as it can be converted into VATS if the lesion is benign or cystic. Thoracotomy is necessary when the mass is malignant or when there is adhesion to or invasion of surrounding tissues.

1980年1月至1997年12月间,我们对21例后纵隔肿块患者进行了观察。所有患者都接受了胸部x线摄影、支气管镜检查、呼吸功能检查、灌注和通气放射性核素扫描、胸部计算机断层扫描(CT)和血气分析。在涉及神经源性肿瘤的病例中,使用磁共振成像(MRI)。10例患者行CT引导下经胸穿刺活检。12例(57.1%)行开胸手术,9例(42.9%)行视频胸腔镜手术;没有死亡记录。11例神经鞘瘤,2例支气管囊肿,2例副神经节瘤,2例神经上皮瘤,1例神经源性肉瘤和3例食管重复。作者认为可以通过CT和MRI对病变进行准确的术前评估。视频辅助胸腔镜(VAT)是一种有用的诊断和治疗方法,因为如果病变是良性或囊性的,它可以转化为VATS。当肿块为恶性或与周围组织有粘连或侵犯时,需要开胸手术。
{"title":"Diagnostic and therapeutic approaches for masses in the posterior mediastinum.","authors":"D Divisi,&nbsp;C Battaglia,&nbsp;R Crisci,&nbsp;L Giusti,&nbsp;A Lococo,&nbsp;M Vaccarili,&nbsp;G F Coloni","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Between January 1980 and December 1997 twenty-one patients with a mass in the posterior mediastinum came under our observation. All of the patients underwent chest radiography, bronchoscopy, respiratory function tests, perfusional and ventilatory radionuclide scans, a computed tomography (CT) of the chest and blood gas analysis. In cases involving neurogenic tumours magnetic resonance imaging (MRI) was used. Ten patients underwent CT guided transthoracic needle biopsy. The excision was performed by means of a thoracotomy in 12 cases (57.1%) and by video assisted thoracoscopy surgery (VATS) in the other 9 (42.9%); no deaths were recorded. Eleven neurilemmomas, two bronchogenic cysts, two paragangliomas, two neuroepitheliomas, one neurogenic sarcoma and three esophageal duplications were found. The authors believe an accurate pre-operative assessment of the lesion can be obtained using CT and MRI. The video assisted thoracoscopy (VAT) is a useful method of diagnosis and treatment as it can be converted into VATS if the lesion is benign or cystic. Thoracotomy is necessary when the mass is malignant or when there is adhesion to or invasion of surrounding tissues.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"69 5-6","pages":"123-8"},"PeriodicalIF":0.0,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21556295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surfactant replacement therapy: a multicentric trial comparing two dosage approaches. 表面活性剂替代疗法:一项比较两种剂量方法的多中心试验。
R M Fiori, E M Diniz, J M Lopes, A L Gonçalves, M T da Costa, W T Marino, V O Abdallah, C A Segre, M de Carvalho, W M Guimarães, P R Margotto, G Bevilacqua

In this study the results of two different initial doses (Group A: 200 mg/kg--82 patients; Group B: 100 mg/kg--83 patients) of a porcine surfactant were compared in the treatment of neonatal respiratory distress syndrome. Main entry criteria were: birth weight between 700 and 2,000 grams, need of mechanical ventilation, FiO2 > or = 0.60 to obtain a PaO2 between 50 and 80 mmHg (PaO2/FiO2 < or = 133.3 mmHg) and less than 15 hours of postnatal age. Two further 100 mg/kg doses could be given in both groups at 12 hours interval if FiO2 was > 0.40. Birth weight (Group A: 1,231 +/- 281 g. and Group B: 1,324 +/- 355 g.), gestational age (Group A: 29.9 +/- 2.7 wk. and Group B: 30.6 +/- 2.6 wk.) and Apgar scores were similar in the two groups. Group A had a significantly higher mean PaO2/FiO2 ratio (p < 0.05) after 12 hours--178 (40-506) vs 133 (17-243) mmHg, before receiving a 2nd dose, after 24 hours--180 (17-431) vs 152 (39-360), and in the 3rd day--177 (40-333) vs 124 (24-249) and needed a lower FiO2 (p < 0.05) after 36 hours (0.47 +/- 0.20 vs 0.53 +/- 0.23) and on the 3rd day (0.51 +/- 0.23 vs 0.61 +/- 0.24). The mean peak inspiratory pressure was lower in Group A at 36 hours (17.5 +/- 4.5 vs 20.6 +/- 6.8) after the initial dose (p < 0.05). The time of exposure to high oxygen concentrations (FiO2 > or = 0.40) was lower in Group A--85 (3-643) vs 131 (3-672) hours; p < 0.05). Total amount of phospholipids given per patient was meanly 224 mg in Group A and 144 mg in Group B. Mortality was lower in group A but without significant difference (Group A: 17/82; Group B: 26/83). The analysis of the subgroup of babies with less than 1,500 gr. at birth showed a statistically significant difference in mortality (Group A: 15/70; Group B: 24/56; p < 0.02).

在本研究中,两种不同初始剂量的结果(A组:200 mg/kg—82例;B组:100 mg/kg(83例)猪表面活性剂治疗新生儿呼吸窘迫综合征。主要入组标准为:出生体重在700 ~ 2000克之间,需要机械通气,FiO2 >或= 0.60以获得PaO2在50 ~ 80 mmHg之间(PaO2/FiO2 <或= 133.3 mmHg),出生后小于15小时。如果FiO2 > 0.40,两组可间隔12 h再给药2次100 mg/kg。出生体重(A组:1231 +/- 281 g, B组:1324 +/- 355 g),胎龄(A组:29.9 +/- 2.7周)。B组:30.6±2.6周),两组Apgar评分相近。A组在接受第二次剂量前,12小时-178 (40-506)vs 133 (17-243) mmHg后,24小时-180 (17-431)vs 152(39-360),第3天-177 (40-333)vs 124(24-249)后,平均PaO2/FiO2比值显著升高(p < 0.05), 36小时(0.47 +/- 0.20 vs 0.53 +/- 0.23)和第3天(0.51 +/- 0.23 vs 0.61 +/- 0.24)后需要较低的FiO2 (p < 0.05)。初始给药后36 h, A组平均峰值吸气压较低(17.5 +/- 4.5 vs 20.6 +/- 6.8) (p < 0.05)。A组暴露于高氧浓度(FiO2 > or = 0.40)的时间-85(3-643)比131(3-672)小时更短;P < 0.05)。A组和b组患者平均每人给予的磷脂总量分别为224 mg和144 mg, A组死亡率较低,但无显著差异(A组:17/82;B组:26/83)。对出生时体重小于1500克的婴儿亚组的分析显示,死亡率有统计学上的显著差异(a组:15/70;B组:24/56;P < 0.02)。
{"title":"Surfactant replacement therapy: a multicentric trial comparing two dosage approaches.","authors":"R M Fiori,&nbsp;E M Diniz,&nbsp;J M Lopes,&nbsp;A L Gonçalves,&nbsp;M T da Costa,&nbsp;W T Marino,&nbsp;V O Abdallah,&nbsp;C A Segre,&nbsp;M de Carvalho,&nbsp;W M Guimarães,&nbsp;P R Margotto,&nbsp;G Bevilacqua","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In this study the results of two different initial doses (Group A: 200 mg/kg--82 patients; Group B: 100 mg/kg--83 patients) of a porcine surfactant were compared in the treatment of neonatal respiratory distress syndrome. Main entry criteria were: birth weight between 700 and 2,000 grams, need of mechanical ventilation, FiO2 > or = 0.60 to obtain a PaO2 between 50 and 80 mmHg (PaO2/FiO2 < or = 133.3 mmHg) and less than 15 hours of postnatal age. Two further 100 mg/kg doses could be given in both groups at 12 hours interval if FiO2 was > 0.40. Birth weight (Group A: 1,231 +/- 281 g. and Group B: 1,324 +/- 355 g.), gestational age (Group A: 29.9 +/- 2.7 wk. and Group B: 30.6 +/- 2.6 wk.) and Apgar scores were similar in the two groups. Group A had a significantly higher mean PaO2/FiO2 ratio (p < 0.05) after 12 hours--178 (40-506) vs 133 (17-243) mmHg, before receiving a 2nd dose, after 24 hours--180 (17-431) vs 152 (39-360), and in the 3rd day--177 (40-333) vs 124 (24-249) and needed a lower FiO2 (p < 0.05) after 36 hours (0.47 +/- 0.20 vs 0.53 +/- 0.23) and on the 3rd day (0.51 +/- 0.23 vs 0.61 +/- 0.24). The mean peak inspiratory pressure was lower in Group A at 36 hours (17.5 +/- 4.5 vs 20.6 +/- 6.8) after the initial dose (p < 0.05). The time of exposure to high oxygen concentrations (FiO2 > or = 0.40) was lower in Group A--85 (3-643) vs 131 (3-672) hours; p < 0.05). Total amount of phospholipids given per patient was meanly 224 mg in Group A and 144 mg in Group B. Mortality was lower in group A but without significant difference (Group A: 17/82; Group B: 26/83). The analysis of the subgroup of babies with less than 1,500 gr. at birth showed a statistically significant difference in mortality (Group A: 15/70; Group B: 24/56; p < 0.02).</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 Suppl 1 ","pages":"55-63"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20895365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intratesticular adenomatoid tumor]. [睾丸内腺瘤样肿瘤]。
A Barbieri, B Monica, N Sebastio, M Ziveri

A case of adenomatoid tumor of the testis is shown. Of this rare benign neoplasm a review of the literature is presented.

睾丸腺瘤样肿瘤1例。这种罕见的良性肿瘤的文献综述提出。
{"title":"[Intratesticular adenomatoid tumor].","authors":"A Barbieri,&nbsp;B Monica,&nbsp;N Sebastio,&nbsp;M Ziveri","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A case of adenomatoid tumor of the testis is shown. Of this rare benign neoplasm a review of the literature is presented.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 1-2","pages":"11-4"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20403993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preeclampsia: correlation between changes in symptomatology and changes in diet. 子痫前期:症状变化与饮食改变的相关性
V Lauro, C Pisani, G Zacchè

This study analyzes 13 cases of pregnant women affected by varying degrees of preeclampsia, and correlates the patients' data (height, weight, preeclampsia symptoms according to intensity and time of onset) to the amount of mean daily intake of nutrients (proteins, lipids, carbohydrates, starch, total calories, Na). The amount of nutrients was obtained processing with a special computer software the patients' weekly dietary diaries. The analysis of the data shows the correlation between the onset of preeclampsia symptomatology and the excess of certain nutrients: excess in calories and/or proteins, and/or lipids, and/or simple sugars, and/or sodium. A reduction in the amount of these nutrients, especially proteins and Na when applied during the early stage of preeclampsia symptoms, favours the disappearance of the clinical signs of the disease.

本研究对13例不同程度子痫前期孕妇进行分析,将患者资料(身高、体重、根据发病强度和时间确定的子痫前期症状)与平均每日营养素摄入量(蛋白质、脂质、碳水化合物、淀粉、总热量、钠)进行关联。通过对患者每周饮食日记的特殊计算机软件处理,得出营养物质的量。数据分析显示子痫前期症状的发生与某些营养物质的过量有关:过量的卡路里和/或蛋白质,和/或脂质,和/或单糖,和/或钠。在子痫前期症状的早期阶段,减少这些营养素的量,特别是蛋白质和钠的量,有利于该疾病的临床症状的消失。
{"title":"Preeclampsia: correlation between changes in symptomatology and changes in diet.","authors":"V Lauro,&nbsp;C Pisani,&nbsp;G Zacchè","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study analyzes 13 cases of pregnant women affected by varying degrees of preeclampsia, and correlates the patients' data (height, weight, preeclampsia symptoms according to intensity and time of onset) to the amount of mean daily intake of nutrients (proteins, lipids, carbohydrates, starch, total calories, Na). The amount of nutrients was obtained processing with a special computer software the patients' weekly dietary diaries. The analysis of the data shows the correlation between the onset of preeclampsia symptomatology and the excess of certain nutrients: excess in calories and/or proteins, and/or lipids, and/or simple sugars, and/or sodium. A reduction in the amount of these nutrients, especially proteins and Na when applied during the early stage of preeclampsia symptoms, favours the disappearance of the clinical signs of the disease.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 Suppl 1 ","pages":"95-8"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20895371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunohematological study in newborn infants with erythroblastosis fetalis transfused in utero. 子宫内输注新生红细胞增多症胎儿的免疫血液学研究。
G Ancora, P Dallacasa, B Gavella, L Calderoni, S Nucci, D Belletti, N A Sorci, R Conte, G P Salvioli

The present study reports immunohematological data (anti-erythrocyte titer, anti-erythrocyte functional activity, percentage of sensitized erythrocytes) in 11 patients with erythroblastosis fetalis transfused in utero (IUTd). At birth it was possible to define two groups of newborns: one with low (group 1) and one with high (group 2) percentage of circulating sensitized erythrocytes, respectively. The presence of a low rate of sensitized red cells at birth in IUTd infants did not reduce the number of exchange transfusions required postnatally. On the contrary, babies of this group were affected by a more severe disease as shown by higher anti-erythrocyte maternal titer, higher anti-erythrocyte functional activity and a higher degree of fetal hemolysis. The persistence of hemolysis after birth, in spite of the absence of sensitized circulating erythrocytes, may be due to intramedullary hemolysis.

本研究报告了11例宫内输血(IUTd)的成红细胞症胎儿的免疫血液学数据(抗红细胞滴度、抗红细胞功能活性、致敏红细胞百分比)。在出生时,可以定义两组新生儿:一组低(组1)和一组高(组2)循环致敏红细胞百分比。宫内节育器婴儿出生时致敏红细胞率低并没有减少出生后所需的交换输血次数。相反,该组婴儿的疾病更为严重,表现为母体抗红细胞滴度较高,抗红细胞功能活性较高,胎儿溶血程度较高。出生后持续溶血,尽管没有致敏循环红细胞,可能是由于髓内溶血。
{"title":"Immunohematological study in newborn infants with erythroblastosis fetalis transfused in utero.","authors":"G Ancora,&nbsp;P Dallacasa,&nbsp;B Gavella,&nbsp;L Calderoni,&nbsp;S Nucci,&nbsp;D Belletti,&nbsp;N A Sorci,&nbsp;R Conte,&nbsp;G P Salvioli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The present study reports immunohematological data (anti-erythrocyte titer, anti-erythrocyte functional activity, percentage of sensitized erythrocytes) in 11 patients with erythroblastosis fetalis transfused in utero (IUTd). At birth it was possible to define two groups of newborns: one with low (group 1) and one with high (group 2) percentage of circulating sensitized erythrocytes, respectively. The presence of a low rate of sensitized red cells at birth in IUTd infants did not reduce the number of exchange transfusions required postnatally. On the contrary, babies of this group were affected by a more severe disease as shown by higher anti-erythrocyte maternal titer, higher anti-erythrocyte functional activity and a higher degree of fetal hemolysis. The persistence of hemolysis after birth, in spite of the absence of sensitized circulating erythrocytes, may be due to intramedullary hemolysis.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 Suppl 1 ","pages":"99-102"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20897798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bronchiolo-alveolar carcinoma. The clinico-diagnostic and therapeutic considerations and the results of a retrospective study in our experience]. [Bronchiolo-alveolar癌。临床诊断和治疗方面的考虑以及我们经验中的回顾性研究结果。
L Calabrese, P Carbognani, L Spaggiari, L Cattelani, P Solli, M Gabrielli, A Bobbio, M Rusca

Bronchioloalveolar carcinoma (BAC) is a subtype of adenocarcinoma of the lung that accounts for 3% of the total pulmonary malignancies. On the basis of literature on the topic, the following were taken into consideration, the history, the incidence, the epidemiology, the aetiopathogenesis, the clinical characteristics, the diagnostic as well as the surgical therapy of this kind of cancer. The authors reviewed our surgical experience of 23 patients treated at the Department of General, Thoracic & Vascular Surgery of the University of Parma during a 10-years period from 1985 to 1995.

细支气管肺泡癌(BAC)是肺腺癌的一种亚型,占肺部恶性肿瘤总数的3%。本文在查阅相关文献的基础上,对该类肿瘤的病史、发病率、流行病学、病因、临床特点、诊断及手术治疗进行了综述。作者回顾了1985年至1995年10年间在帕尔马大学普通胸外科和血管外科治疗的23例患者的手术经验。
{"title":"[Bronchiolo-alveolar carcinoma. The clinico-diagnostic and therapeutic considerations and the results of a retrospective study in our experience].","authors":"L Calabrese,&nbsp;P Carbognani,&nbsp;L Spaggiari,&nbsp;L Cattelani,&nbsp;P Solli,&nbsp;M Gabrielli,&nbsp;A Bobbio,&nbsp;M Rusca","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bronchioloalveolar carcinoma (BAC) is a subtype of adenocarcinoma of the lung that accounts for 3% of the total pulmonary malignancies. On the basis of literature on the topic, the following were taken into consideration, the history, the incidence, the epidemiology, the aetiopathogenesis, the clinical characteristics, the diagnostic as well as the surgical therapy of this kind of cancer. The authors reviewed our surgical experience of 23 patients treated at the Department of General, Thoracic & Vascular Surgery of the University of Parma during a 10-years period from 1985 to 1995.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 5-6","pages":"87-105"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20897800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period. 新生儿期表面活性剂对早产儿呼吸力学的影响。
S Parmigiani, C Panza, G Bevilacqua

Objective: To evaluate the development of the lung of preterm infants given exogenous surfactant in the neonatal period versus control babies through the evolution of respiratory mechanics (RM) parameters.

Patients and methods: Retrospective analysis of babies < or = 30 weeks' gestation admitted to our intensive care unit in the period 1990-94 in which RM parameters had been followed for the first two years of life. Babies were divided into two groups depending on the fact that they received endotracheal porcine surfactant 200 mg/kg for prophylaxis or rescue treatment of respiratory distress syndrome (RDS) (treatment group, No.37) or not (control group, No.41). Evaluation of RM were performed by means of PèDS at the post-conceptual age of 38-42 wks and/or 3-6 mth and/or 9-12 mth and/or 18-24 mth in spontaneous breathing after sedation with chloral hydrate and positioning of an oesophageal balloon. Chronic lung disease (CLD) was defined a posteriori as presence of polypnea at discharge independently from oxygen-therapy and from radiological findings, including also the most severe forms of bronchopulmonary dysplasia.

Results: The treatment and control group did not differ for birth weight and gestational age (1060 +/- 293 vs 1189 +/- 321 g. and 28.1 vs 28.3 +/- 1.5 wks respectively), however the babies of the treatment group had higher incidence of RDS, mechanical ventilation, nasal continuous positive airway pressure, and use of caffeine (p < 0.01 vs the control group). No difference was found in the incidence of CLD at discharge between the two groups. No difference was found between the treatment and the control group at the various times of the examinations concerning respiratory frequency, tidal volume, minute ventilation, dynamic compliance of the respiratory system (indexed both to body weight and length), and respiratory system resistances. The above cited parameters, except respiratory system resistances, showed significant changes from the first to the last evaluation (p < 0.01) in both groups, indicating a continuous improvement of the RM properties of the lung in the first two years of life. As regards respiratory system resistances, these were significantly reduced in the first two years of life in the treatment group (from 73.9 +/- 38.5 to 31.3 +/- 5.8 cmH2O/L/sec; p < 0.05), while there was no significant improvement in the control group (from 65.1 +/- 26.1 to 42.8 +/- 41.6 cmH2O/L/sec; p = ns).

Conclusion: The use of surfactant both as prophylactic and rescue treatment of RDS seems able to guarantee the lung of the preterm infant to develop in a regular way, in spite of high incidence of respiratory diseases and unfavourable effects of respiratory therapies. This study also allows to have standard reference values of RM parameters for ex-preterm infants in the first two years of life to evaluate their lung development.

目的:通过呼吸力学(RM)参数的演化,评价新生儿期外源性表面活性剂对早产儿肺发育的影响。患者和方法:回顾性分析1990- 1994年期间入住我们重症监护室的<或= 30孕周的婴儿,其中在生命的头两年遵循RM参数。根据是否接受气管内猪表面活性剂200mg /kg预防或抢救呼吸窘迫综合征(RDS)治疗(治疗组,编号37)和未接受气管内猪表面活性剂预防或抢救治疗(对照组,编号41)将患儿分为两组。经水合氯醛镇静和食管球囊定位后,孕后年龄38-42周和/或3-6个月和/或9-12个月和/或18-24个月自主呼吸时,通过ppts评估RM。慢性肺部疾病(CLD)被定义为出院时出现呼吸急促,独立于氧疗和放射学表现,包括最严重的支气管肺发育不良。结果:治疗组与对照组出生体重、胎龄差异无统计学意义(1060 +/- 293 g vs 1189 +/- 321 g, 28.1 +/- 1.5周),但治疗组婴儿RDS、机械通气、鼻持续气道正压、咖啡因使用发生率高于对照组(p < 0.01)。两组患者出院时CLD发生率无差异。在呼吸频率、潮气量、分钟通气量、呼吸系统动态顺应性(以体重和体长为指标)和呼吸系统阻力的不同检查时间,治疗组和对照组之间没有差异。上述参数除呼吸系统阻力外,两组在第一次和最后一次评估时均有显著变化(p < 0.01),说明肺的RM特性在生命的前两年持续改善。在呼吸系统阻力方面,治疗组在生命的头两年显著降低(从73.9 +/- 38.5降至31.3 +/- 5.8 cmH2O/L/sec;p < 0.05),而对照组无显著改善(从65.1 +/- 26.1 cmH2O/L/sec降至42.8 +/- 41.6 cmH2O/L/sec;P = ns)。结论:尽管呼吸道疾病发病率高,呼吸治疗效果不佳,但表面活性剂作为RDS的预防和抢救治疗似乎可以保证早产儿肺部的正常发育。本研究也允许有标准的参考值RM参数的前早产儿在生命的头两年,以评估其肺发育。
{"title":"Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.","authors":"S Parmigiani,&nbsp;C Panza,&nbsp;G Bevilacqua","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the development of the lung of preterm infants given exogenous surfactant in the neonatal period versus control babies through the evolution of respiratory mechanics (RM) parameters.</p><p><strong>Patients and methods: </strong>Retrospective analysis of babies < or = 30 weeks' gestation admitted to our intensive care unit in the period 1990-94 in which RM parameters had been followed for the first two years of life. Babies were divided into two groups depending on the fact that they received endotracheal porcine surfactant 200 mg/kg for prophylaxis or rescue treatment of respiratory distress syndrome (RDS) (treatment group, No.37) or not (control group, No.41). Evaluation of RM were performed by means of PèDS at the post-conceptual age of 38-42 wks and/or 3-6 mth and/or 9-12 mth and/or 18-24 mth in spontaneous breathing after sedation with chloral hydrate and positioning of an oesophageal balloon. Chronic lung disease (CLD) was defined a posteriori as presence of polypnea at discharge independently from oxygen-therapy and from radiological findings, including also the most severe forms of bronchopulmonary dysplasia.</p><p><strong>Results: </strong>The treatment and control group did not differ for birth weight and gestational age (1060 +/- 293 vs 1189 +/- 321 g. and 28.1 vs 28.3 +/- 1.5 wks respectively), however the babies of the treatment group had higher incidence of RDS, mechanical ventilation, nasal continuous positive airway pressure, and use of caffeine (p < 0.01 vs the control group). No difference was found in the incidence of CLD at discharge between the two groups. No difference was found between the treatment and the control group at the various times of the examinations concerning respiratory frequency, tidal volume, minute ventilation, dynamic compliance of the respiratory system (indexed both to body weight and length), and respiratory system resistances. The above cited parameters, except respiratory system resistances, showed significant changes from the first to the last evaluation (p < 0.01) in both groups, indicating a continuous improvement of the RM properties of the lung in the first two years of life. As regards respiratory system resistances, these were significantly reduced in the first two years of life in the treatment group (from 73.9 +/- 38.5 to 31.3 +/- 5.8 cmH2O/L/sec; p < 0.05), while there was no significant improvement in the control group (from 65.1 +/- 26.1 to 42.8 +/- 41.6 cmH2O/L/sec; p = ns).</p><p><strong>Conclusion: </strong>The use of surfactant both as prophylactic and rescue treatment of RDS seems able to guarantee the lung of the preterm infant to develop in a regular way, in spite of high incidence of respiratory diseases and unfavourable effects of respiratory therapies. This study also allows to have standard reference values of RM parameters for ex-preterm infants in the first two years of life to evaluate their lung development.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 Suppl 1 ","pages":"65-73"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20895366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group. 早产儿视网膜病变和产前皮质类固醇。意大利ROP研究小组。
V Console, L Gagliardi, A De Giorgi, E De Ponti

Objectives: It is not known whether antenatal corticosteroids (ANS) can reduce the risk of retinopathy of prematurity (ROP). The aim of this study was to evaluate in a prospective cohort study the effect of ANS on ROP development and severity.

Methods: All infants consecutively admitted to 14 centres from 1.1.1992 to 31.12.1993, with a gestational age < or = 30 weeks, no congenital anomalies, and who survived to 6 months, were enrolled (N = 380). Mean birth weight of the cohort was 1157 g; mean gestational age was 28.4 weeks. ROP stage 1-2 developed in 82 neonates; ROP stage 3-3+ in 57. Only 70 neonates (18.4%) received ANS prophylaxis.

Results: ANS prophylaxis highly significantly reduced the risk of developing ROP [Odds ratio, (OR), 0.35; 95% confidence interval 0.17-0.71, logistic regression analysis], and that of severe (stage 3-3+) ROP (OR 0.07; 95% confidence interval: 0.02-0.34). Short gestation, low birth weight, bronchopulmonary dysplasia also were significantly associated with ROP development and severity; respiratory distress syndrome and not being treated with surfactant were significant risk factors for ROP severity.

Conclusions: ANS prophylaxis protected both against ROP development and against severe forms of ROP. Prematurity and respiratory morbidity still represent independent risk factors for ROP.

目的:尚不清楚产前皮质类固醇(ANS)是否能降低早产儿视网膜病变(ROP)的风险。本研究的目的是在一项前瞻性队列研究中评估ANS对ROP发展和严重程度的影响。方法:选取1992年1月1日至1993年12月31日在14个中心连续就诊、胎龄<或= 30周、无先天性异常、存活至6个月的新生儿380例。该队列的平均出生体重为1157 g;平均胎龄28.4周。82例新生儿出现1-2期ROP;ROP达到3-3+。只有70名新生儿(18.4%)接受了ANS预防。结果:ANS预防可显著降低发生ROP的风险[优势比,(OR), 0.35;95%可信区间0.17-0.71,logistic回归分析],严重(3-3+期)ROP (OR 0.07;95%置信区间:0.02-0.34)。妊娠期短、出生体重低、支气管肺发育不良也与ROP的发生和严重程度显著相关;呼吸窘迫综合征和未使用表面活性剂治疗是ROP严重程度的重要危险因素。结论:ANS预防对ROP的发展和严重形式的ROP都有保护作用。早产和呼吸系统疾病仍然是ROP的独立危险因素。
{"title":"Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group.","authors":"V Console,&nbsp;L Gagliardi,&nbsp;A De Giorgi,&nbsp;E De Ponti","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>It is not known whether antenatal corticosteroids (ANS) can reduce the risk of retinopathy of prematurity (ROP). The aim of this study was to evaluate in a prospective cohort study the effect of ANS on ROP development and severity.</p><p><strong>Methods: </strong>All infants consecutively admitted to 14 centres from 1.1.1992 to 31.12.1993, with a gestational age < or = 30 weeks, no congenital anomalies, and who survived to 6 months, were enrolled (N = 380). Mean birth weight of the cohort was 1157 g; mean gestational age was 28.4 weeks. ROP stage 1-2 developed in 82 neonates; ROP stage 3-3+ in 57. Only 70 neonates (18.4%) received ANS prophylaxis.</p><p><strong>Results: </strong>ANS prophylaxis highly significantly reduced the risk of developing ROP [Odds ratio, (OR), 0.35; 95% confidence interval 0.17-0.71, logistic regression analysis], and that of severe (stage 3-3+) ROP (OR 0.07; 95% confidence interval: 0.02-0.34). Short gestation, low birth weight, bronchopulmonary dysplasia also were significantly associated with ROP development and severity; respiratory distress syndrome and not being treated with surfactant were significant risk factors for ROP severity.</p><p><strong>Conclusions: </strong>ANS prophylaxis protected both against ROP development and against severe forms of ROP. Prematurity and respiratory morbidity still represent independent risk factors for ROP.</p>","PeriodicalId":6943,"journal":{"name":"Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma","volume":"68 Suppl 1 ","pages":"75-9"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20895367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1